| Literature DB >> 25218201 |
Andrei P Drabovich1, Eduardo Martínez-Morillo2, Eleftherios P Diamandis3.
Abstract
Protein biomarker development is a multidisciplinary task involving basic, translational and clinical research. Integration of multidisciplinary efforts in a single pipeline is challenging, but crucial to facilitate rational discovery of protein biomarkers and alleviate existing disappointments in the field. In this review, we discuss in detail individual phases of biomarker development pipeline, such as biomarker candidate identification, verification and validation. We focus on mass spectrometry as a principal technique for protein identification and quantification, and discuss complementary -omics approaches for selection of biomarker candidates. Proteomic samples, protein-based clinical laboratory tests and limitations of biomarker development are reviewed in detail, and critical assessment of all phases of biomarker development pipeline is provided. This article is part of a Special Issue entitled: Medical Proteomics.Keywords: Biomarker discovery; Biomarker validation; Biomarker verification; Mass spectrometry; Protein biomarker; Proteomics
Mesh:
Substances:
Year: 2014 PMID: 25218201 DOI: 10.1016/j.bbapap.2014.09.006
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002